Ram Aiyar
Net worth: 920 001 $ as of 2026-08-30
Net worth: 920 001 $ as of 2026-08-30
Ram Aiyar was the founder of Corvidia Therapeutics, Inc., founded in 2015, where the title held was CFO, Executive VP & Head-Business Development in 2020.
Dr. Aiyar is also the founder of Protean Bio, Inc...
Current jobs include President, Chief Executive Officer & Director at Korro Bio, Inc. (United States) since 2020; President, CEO, CFO & Director at Korro Bio, Inc. starting 2025; Director at Triveni Bio, Inc.; and Advisor at Atlas Venture Advisors, Inc. Former jobs include Director at Avidea Technologies, Inc.; Chief Commercial Officer at FlowMetric LLC from 2012 to 2013; and Associate at Sofinnova Partners SAS from 2011 to 2012.
Education includes graduate and doctorate degrees from Drexel University, an MBA from INSEAD, and an undergraduate degree from the University of Mumbai conferred in 1999.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.5% | 2026-08-03 | 73,659 ( 0.5% ) | 920 001 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Chief Executive Officer | 2020-11-09 |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
| Companies | Position | End |
|---|---|---|
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Founder | 2020-10-31 |
FlowMetric LLC
FlowMetric LLC Medical/Nursing ServicesHealth Services Provides pre-clinical, toxicology & safety, clinical and cell sorting services | Corporate Officer/Principal | 2013-04-30 |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Private Equity Analyst | 2012-09-30 |
Avidea Technologies, Inc.
Avidea Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops T cell immunotherapies for treating cancer, infections and autoimmune diseases | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
FlowMetric LLC
FlowMetric LLC Medical/Nursing ServicesHealth Services Provides pre-clinical, toxicology & safety, clinical and cell sorting services | Health Services |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Finance |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Health Technology |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
Avidea Technologies, Inc.
Avidea Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops T cell immunotherapies for treating cancer, infections and autoimmune diseases | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions